VANCOUVER, BC
and MESA, AZ, Aug. 22, 2013 /CNW/ - Avidus Management Group
Inc. ("Avidus" or the "Company") (TSX-V: AVD, OTC: ASNHF) announced
today that Asantae, its wholly owned subsidiary, has successfully
recruited Erik Cloud to lead
Asantae's network marketing related initiatives.
Hailing from Boise,
Idaho, Mr. Cloud has been a full-time networking
professional for 15 years and is a proven public speaker, teacher
and trainer. During his successful networking marketing
career, he has been mentored by some of the preeminent networking
professionals and has built sales organizations that number in the
tens of thousands. He brings geographic diversity for Asantae
with key distributor groups in the Pacific Northwest. Mr.
Cloud was a leading author and played a vital role in the
development of the Fast Track Business Building system.
Avidus also announced that it will begin selling
its network marketing tools and sales aids through a newly created
division, Fast Track Systems. "Creating a division to sell its
business tools represents an important step for Avidus in achieving
its mission to provide standardized business building systems for
its related companies," said Avidus President, Doug Ridley.
The tools are based upon business building
methods that have long been acknowledged throughout the industry as
the gold standard. The first tools to be introduced are a
uniform business presentation for recruiting, a standardized
methodology to launch a new distributor's business supported by a
comprehensive training manual to assist distributors with
developing long-term success through duplication.
About Avidus
Avidus Management Group Inc. (www.asantae.com)
(TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary,
Asantae, develops, produces and markets innovative nutritional
products through direct and network marketing channels. The
ingredients in Asantae's products have been shown to reduce chronic
low-grade inflammation and oxidative stress, and support a healthy
immune system that, according to scientific and medical research,
are the underlying conditions for most modern epidemic diseases
(diabetes, heart disease, obesity, stroke, etc.).
This news release may contain forward-looking statements
relating to the Company's operations or to the environment in which
it operates. Such statements are based on operations, estimates,
forecasts and projections. They are not guarantees of future
performance and involve risks and uncertainties that are difficult
to predict and may be beyond the Company's control. A number of
important factors could cause actual outcomes and results to differ
materially from those expressed in forward-looking statements,
including those set forth in the Company's regulatory filings. In
addition, such statements relate to the date on which they are made
and the Company disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, save and except as may be
required by applicable securities laws.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
SOURCE Avidus Management Group Inc.